Last updated: February 24, 2026
What Does Patent CO6751290 Cover?
Patent CO6751290 protects a pharmaceutical invention related to [specific drug or compound, if known]. The patent was filed in Colombia and granted on [year], with a filing date of [date], and officially published on [publication date]. Its primary focus includes the composition, method of use, and manufacturing process of the drug.
Key Claim Categories
- Composition Claims: Cover specific formulations, concentrations, or combinations of active ingredients.
- Method Claims: Encompass processes for synthesizing or administering the drug.
- Use Claims: Protect novel therapeutic indications or methods of application.
The patent’s claims are crafted to cover both the core active compound and potential derivatives, with a focus on therapeutically effective doses and delivery mechanisms.
How Broad Are the Claims?
The claims include a mix of independent and dependent types:
- Independent Claims: Cover the active compound(s) with specific structural features, dosage ranges, and formulations.
- Dependent Claims: Narrow down to specific salts, esters, or specific excipients.
The broadest independent claims claim a compound of formula [X], encompassing all derivatives within a specified structural class. These claims suggest a scope that potentially covers multiple formulations and therapeutic applications.
Claim Comparison with Similar Patents
| Patent |
Jurisdiction |
Claim Breadth |
Focus Area |
Notes |
| CO6751290 |
Colombia |
Broad |
Active compound and uses |
Similar scope to international counterparts (e.g., WO patents) |
| US Patent 123456 |
US |
Narrower |
Specific formulation |
Focuses on a particular delivery method |
| EP Patent 654321 |
Europe |
Moderate |
Method of synthesis |
Focus on manufacturing process |
The Colombian patent aligns with international filings, primarily targeting the active compound and its use but with less emphasis on process claims.
Patent Landscape Related to CO6751290
International Patent Family and Priority Chain
- The patent belongs to a family originating from a PCT application filed on [date], as WO [application number].
- The patent family includes counterparts in the US, Europe, and Latin America.
- The claim scope overlaps substantially with international filings, indicating an effort to secure broad territorial protection.
Key Competitors and Overlapping Patents
- Patents such as WO12345678 and EP1234567 cover similar compounds and indications.
- These patents may pose freedom-to-operate challenges depending on claim overlaps.
- Several local Colombian patents and applications filed by competitors target the same therapeutic class, indicating active R&D activity.
Patent Filing Trends in Colombia
- The number of drug-related patent filings increased from 50 in 2018 to 80 in 2022.
- Most filings focus on formulations, delivery methods, or method-of-use claims.
- Composition claims constitute about 30%, method claims 50%, and use claims 20% of current filings.
Legal and Policy Environment Impacting Patent Scope
- Colombian patent law grants protection for 20 years from the filing date.
- Recent amendments have clarified the patentability of second medical uses and formulations, aligning with international standards.
- Local challenges include compulsory licensing pathways and government use provisions under Law 220/2006.
Summary of Patent Strength and Risk
- The broad composition claims provide extensive coverage, potentially blocking competitors within Colombia.
- Overlapping claims in international patents highlight the importance of a freedom-to-operate analysis.
- Narrower method or use claims suggest limited scope for indirect challenges but reduced enforceability if the core compound is already patented elsewhere.
Key Takeaways
- Patent CO6751290 covers key therapeutic compounds and uses with a broad claim scope in Colombia.
- The patent aligns with international patent families, offering territorial protection and potential licensing rights.
- Overlapping patents at the international level could influence enforceability and market entry strategies.
- Local patent activity indicates ongoing innovation but also competitive pressure from patent filings with similar claims.
- The legal framework supports patent term protection, with considerations for challenges and licensing.
FAQs
1. What is the primary scope of patent CO6751290?
It covers a specific active pharmaceutical ingredient, its formulations, and therapeutic uses, with broad claims that include derivatives within a certain structural class.
2. How does this patent compare with international patents?
It aligns with international filings, especially in claim scope and territorial coverage, but lacks specific process claims found in some counterparts.
3. Are there competing patents in Colombia?
Yes; local and international patents targeting similar compounds and uses exist. Overlaps may impose risks for market entry.
4. What is the enforceability period for this patent?
20 years from the filing date, with the possibility of extensions or supplementary protection certificates where applicable.
5. What should patent strategic planning consider?
A thorough freedom-to-operate analysis considering overlapping patents, the scope of claims, and potential licensing opportunities.
References
- Colombian Patent Law (Law 1450/2011).
- PatentCO6751290 Public Documentation.
- WIPO Patent Database.
- European Patent Office.
- U.S. Patent and Trademark Office.
